Michael D. West
2011 - BioTime
In 2011, Michael D. West earned a total compensation of $856.2K as Chief Executive Officer at BioTime, a 45% increase compared to previous year.
Compensation breakdown
| Bonus | $266,000 |
|---|---|
| Option Awards | $10,664 |
| Salary | $560,500 |
| Other | $19,038 |
| Total | $856,202 |
West received $560.5K in salary, accounting for 65% of the total pay in 2011.
West also received $266K in bonus, $10.7K in option awards and $19K in other compensation.
Rankings
In 2011, Michael D. West's compensation ranked 6,215th out of 10,747 executives tracked by ExecPay. In other words, West earned more than 42.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,215 out of 10,747 | 42nd |
Division Manufacturing | 2,251 out of 3,960 | 43rd |
Major group Chemicals And Allied Products | 511 out of 1,038 | 51st |
Industry group Drugs | 335 out of 786 | 57th |
Industry Biological Products, Except Diagnostic Substances | 52 out of 162 | 68th |
Source: SEC filing on October 14, 2014.
West's colleagues
We found three more compensation records of executives who worked with Michael D. West at BioTime in 2011.
News
AgeX Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
AgeX Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
AgeX Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019